Sentinel nodes outside level I-II of the axilla and staging in breast cancer

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 3109-3112

  Ronka R ^a   Krogerus, L ^a   Leppanen E ^a   Smitten, K V ^a   Leidenius, M ^a  

^a Maria Hospital   (Finland)

Author keywords

Breast cancer; Internal mammary lymph nodes; Sentinel node biopsy

Indexed keywords

ALBU RES; ALBUMIN TC 99M COLLOID;

ADULT; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BIOPSY; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0036765978     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Morrow M and Foster RS: Staging of breast cancer. A new rationale for internal mammary node biopsy. Arch Surg 166: 748-751, 1981.
2. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I and Mizukami Y: Reappraisal of internal mammary node metastases as a prognostic factor on patients with breast cancer. Cancer 68: 1918-1925, 1991.
3. Veronesi U, Cascinelli N, Greco S et al: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707, 1985.
4. Donegan WL: The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 39: 533-538, 1977.
5. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U and Hill C: Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 51: 1941-1943, 1983.
6. Freedman GM, Fowble BL, Nicolaou N et al: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist. Int J Radiation Oncology Biol Phys 46: 805-814, 2000.
7. Albertini JJ, Lyman GH, Cox C et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818-1822, 1996.
8. Giuliano AE, Kirgan DM, Guenther GM and Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994.
9. Jansen L, Doting MHE, Rutgers EJ, de Vries J, Valdés Olmos RA and Nieweg OE: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 87: 920-925, 2000.
10. van der Ent FWC, Kengen RAM, van der Pol HAG et al: Helsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234: 79-84, 2001.
11. Borgestein PJ, Pijpers R, Comans EF, Diest PJ, Boom RP and Meijer S: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186: 275-283, 1998.
12. Uren RF, Howman-Giles R, Renwick SB and Gillet D: Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg 25: 789-793, 2001.
13. Krag D, Weaver D, Ashikaga T et al: The Sentinel node in breast cancer-a multicenter validation study. NEJM 339: 941-946, 1998.
14. O'Hea BJ, Hill EDK, El-Shirbiny AM et al: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer, Center. J Am Coll Surg 186: 423-427, 1998.
15. Haigh PI, Hansen NM, Giuliano AE, Edwards GK, Ye W and Glass EC: Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 41: 1682-1688, 2000.
16. Valdës Olmos RA, Tanis PJ, Hoefnagel CA et al: Improved sentinel node visualization in breast cancer by optimazing the colloid particle concentration and tracer dosage. Nucl Med Commun 22: 579-586, 2001.
17. Recht A, Edge SM, Solin LJ et al: Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19: 1539-1569, 2001.